Bumps and lumps of the hand are a common cause for consultation in general practice. However not all of these lesions are of true neoplastic nature and malignant tumours are a rarity in this location. The records of all tumours of the hand and wrist treated surgically at our institution in the period 1994 to 2009 were reviewed. Because of their non-neoplastic nature typical lesions of the hand such as ganglion cysts or palmar fibromatosis and the like were not included in this study. Histological entity, location, radiographic and clinical findings were analysed; malignant tumours were followed up by X-ray and MRI.Aim
Method
Of the 339 patients, 218 were available for follow-up, 72 had died, 38 without revision surgery were contacted by phone and 11 were lost to follow-up. The underlying pathology was idiopathic degenerative joint disease (153 pts.), dysplastic OA (37 pts.), femoral head necrosis (12 pts.), posttraumatic OA (6 pts.) and OA of other origins (5 pts.). To evaluate changes in stem position, radiolucent lines, osseointegration and revision, clinical and monitor-controlled radiographic follow-ups were conducted at 10 years plus.
At the 10 year follow-ups (10,0 to 11,1, mean 10,2 years) the stem position was unchanged in all of the 213 patients. The stems had been implanted in proper anatomical alignment in 196 patients, in varus in 16 and in valgus in one patient. 93 patients showed no changes of the peri-implant bone. In 96 peri-implant bone apposition was recorded in one or more zones (Gruen). 20 patients presented with radiologic evidence of both peri-implant bone apposition and some atrophy. None of these patients showed abnormalities clinically (HHS: 95.2; 76–100). At the 10-year follow-ups 2 stems had worked loose. Another 2 patients presented with intertrochan-teric osteolyses with definite progression versus the 5-year follow-up. On analysis, radiolucent lines (RLs) were seen in zone 1 in 28.6% of cases, in zones 2 and 6 in 3.3%, in zones 3, 4 and 5 in 0.5% and in zone 7 in 22.1%. The Kaplan-Meier survival rate was 98.2% (CI 95.3 to 99.2) with revision of the stem for any reason as the end point (N = 339).